Assessment of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) as Measured Using a New Device (Inflammacheck™) in Patients With Interstitial Lung Disease, Lung Cancer and Healthy Volunteers.
CompletedOBSERVATIONAL
Enrollment
37
Participants
Timeline
Start Date
October 30, 2018
Primary Completion Date
September 14, 2019
Study Completion Date
September 14, 2019
Conditions
Interstitial Lung DiseaseLung Cancer
Trial Locations (1)
PO6 3LY
Portsmouth Hospitals NHS Trust, Portsmouth
All Listed Sponsors
lead
Portsmouth Hospitals NHS Trust
OTHER_GOV
NCT04061356 - Assessment of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) as Measured Using a New Device (Inflammacheck™) in Patients With Interstitial Lung Disease, Lung Cancer and Healthy Volunteers. | Biotech Hunter | Biotech Hunter